Skip to main content
Premium Trial:

Request an Annual Quote

Greg Weaver, Henry Costantino, Paul Johnson

Premium
Scolr Pharma said this week that it has appointed Greg Weaver to its board of directors.
 
Weaver is currently CFO of Talyst, a provider of automated pharmacy solutions. He was previously CFO of Sirna Therapeutics.
 

 
Nastech Pharmaceutical said last week that it has promoted Henry Costantino to CSO of delivery, following the resignation of former CSO Paul Johnson.
 
Costantino previously served as director of formulations at Nastech and was recently promoted to vice president of pharmaceutical research and development. Before Nastech, he worked at Alkermes and Genentech.
 
He holds BS and MS degrees from Johns Hopkins University, and a PhD in chemical engineering from the Massachusetts Institute of Technology.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.